Overview

Tonsil masses are abnormal swellings of the palatine tonsils secondary to benign developments like reactive hyperplasia or malignancies in the form of lymphoma or squamous cell carcinoma. Early diagnosis helps to provide appropriate treatment and improvement. Fine Needle Aspiration Cytology (FNAC) is an outpatient procedure where a fine needle is used to aspirate cells for microscopic examination, a quick and cost-effective method to classify between malignant and benign lesions. This article discusses the role of FNAC in diagnosing tonsil masses, its accuracy, benefits, disadvantages, and comparison with other diagnostic techniques to identify its clinical value.

Anatomy and pathology of tonsil masses

Normal anatomy and function of tonsils

Tonsils are part of the lymphatic system and are located at the back of the throat within the oropharynx. They are made up of lymphoid tissue and play a role in the immune system by trapping and identifying pathogens that enter the body through the mouth and nose. Palatine tonsils, which are most often found in, contain crypts that increase their surface area to identify antigens and develop an immune response. 

Common types of tonsil masses

Benign lesions:¹

• Reactive lymphoid hyperplasia: Non-malignant enlargement secondary to infections
• Papillomas: Wart-like lesions caused by human papillomavirus (HPV)
• Tonsil stones: Calcified material in crypts causing halitosis

Malignant lesions:¹

• Squamous cell carcinoma (SCC): A Broader cancer of smoking, alcohol, and HPV
• Lymphoma: Blood malignancy resulting in tonsil enlargement, night sweats, and weight loss
• Metastatic tumours: Secondary deposits of other cancers, indicating advanced disease

Clinical presentation and differential diagnosis

Patients with tonsillar masses may have a painless sore throat, dysphagia (difficulty in swallowing), unilateral tonsillar swelling, otalgia, or airway obstruction. There may be other systemic features in malignant conditions, such as unexpected weight loss, night sweats, and lymphadenopathy in cervical nodes.²

Differential diagnosis of tonsil mass consists of benign reactive hyperplasia, chronic tonsillitis, abscess formation, papillomas, and malignancies like SCC or lymphoma. ¹ Diagnostic methods like FNAC, imaging (CT, MRI), and histopathological biopsy are used to rule out these conditions and plan an appropriate treatment.²

Fine needle aspiration cytology (FNAC)

FNAC is a minimally invasive diagnostic method using a fine needle to aspirate cellular samples from a lesion for cytological examination. It is valued for its simplicity, cost-effectiveness, and ability to provide rapid preliminary diagnoses.

FNAC is advised for suspected malignancy of tonsil masses and chronic enlargement. It helps differentiate reactive lymphoid hyperplasia, infection, and malignancies like lymphoma or SCC. The procedure involves insertion of a fine-gauge needle (22-25 gauge) into the mass, preferably with the help of ultrasound, with the use of negative pressure to aspirate cells and preparation of slides for microscopy. Liquid-based cytology can be used for better preservation of the sample.³

Though FNAC is normally safe, the complications are mild and include pain, minimal bleeding, and rarely, infection. Its limitations are the inability to take sufficient samples from the tonsil's deep-seated location, false negatives, and histopathological biopsy in case of inadequate findings.⁴

Diagnostic accuracy and utility of FNAC

Sensitivity and specificity of malignancy detection   

FNAC is very sensitive and specific for malignancy detection in tonsil masses. FNAC sensitivity for the detection of malignant lesions is generally 93.5%, thus identifying the presence of cancer cells with accuracy. However, its specificity is also high, typically 96.2%, so that it is generally accurate in confirming that a mass is malignant. This makes FNAC an important diagnostic modality for malignancy detection, especially where early diagnosis is crucial.⁴

Comparison with other diagnostic modalities

Clinical examination

Clinical examination alone is not sensitive for tonsil mass diagnosis since it relies mainly on palpation and visible examination of the tonsils, which could be insensitive when faced with deep-set or small masses. Though it can alert one to enlarging or visible masses, it neither provides the necessary cellular detail as would FNAC nor considers clinical findings.

Imaging (CT, MRI, ultrasound)

 Imaging modalities such as CT, MRI, and ultrasound can provide good information on size, site, and spread of a tonsillar mass. Though these are important to explain the lesion and determine spread, they will not provide ultimate information about the cellular nature of the mass. However, FNAC will allow a more precise diagnosis by providing cellular information, and therefore helpful in distinguishing benign vs malignant masses.⁴

Histopathological biopsy

A histopathological biopsy remains the gold standard for a definitive diagnosis because it provides an overall impression of tissue architecture and cellular morphology.⁵ However, biopsy is more invasive than FNAC and usually requires anaesthesia and a longer recovery time. FNAC is less invasive and can typically provide similar diagnostic information, particularly for malignancies, although biopsy may still be necessary for a more detailed analysis, particularly when FNAC results are undefined.⁵

Advantages of FNAC in early diagnosis

There are numerous advantages of FNAC in early tonsil mass diagnosis. Firstly, FNAC is less invasive and most often performed under local anaesthesia, allowing for a quicker diagnosis and less patient pain compared to biopsy. Secondly, FNAC provides rapid results so that clinicians are able to decide faster on the treatment options, specifically in case of suspicion of malignancy. It can also be performed in an outpatient setting, thus being more cost-effective and convenient. Lastly, FNAC can avoid unnecessary surgeries by identifying benign conditions early on, hence avoiding more invasive interventions unless absolutely needed.^4,5

Challenges and limitations of FNAC in tonsil masses

FNAC for the diagnosis of tonsil masses faces several challenges.⁶ Firstly, there is sampling difficulty due to anatomical constraint within the tonsils, where the latter is in the deep position of the oropharynx with nearness to life structures like blood vessels, nerves, and the airway, making accurate targeting of the mass more difficult. Also, there can be a chance of non-diagnostic or suboptimal specimens, especially if the needle cannot penetrate the lesion sufficiently or the specimen does not have sufficient cellular material for evaluation. This is enhanced when the mass is heavy or in a location that is not easily accessed. Likewise, FNAC can sometimes require extra histopathological correlation, since it may not provide enough cellular detail or may lead to inconclusive results. In such cases, a biopsy or additional tissue sampling would be required to make a better diagnosis, mainly in the event of suspected malignancy.⁶

Clinical and practical implications

FNAC plays a role in treatment planning for tonsil masses through the establishment of a rapid and accurate diagnosis. This helps to verify whether a mass is malignant or benign, which directly impacts treatment options such as surgery, chemotherapy, or radiotherapy. In malignant lesions, FNAC also stages the cancer, identifies the type of malignancy, and whether the mass is primary or metastatic, allowing personalised treatment planning. FNAC has minimally invasive diagnostic modalities by enabling tissue sampling through a fine needle, reducing patient discomfort, recovery time, and avoiding complications of more invasive biopsies. This also makes it an appropriate option for the primary evaluation of tonsil masses, especially in the outpatient setting.²

In the future, advancements in imaging modalities, for example, ultrasound-guided FNAC, can increase accuracy, with less chance of non-diagnostic or false-negative results.⁷ In addition, ongoing research in enhancing molecular examination of FNAC samples can provide more precise data about tumour markers and gene mutations, leading to more personalised treatment approaches and better patient outcomes.⁸

FAQs

Is FNAC painful?

FNAC is usually not very painful; most patients feel only mild discomfort, like a blood test.

How long does the FNAC procedure take?

The procedure typically takes about 10-15 minutes.

Are there any risks associated with FNAC?

FNAC is generally safe, with minimal risks such as mild bleeding, bruising, or discomfort at the needle insertion site.

When will I receive FNAC results?

Results are usually available within a few days to a week, depending on the laboratory.

Are all tonsil masses cancerous?

No, many tonsil masses are benign, such as tonsil stones, cysts, or infections, but some may require further evaluation for malignancy.

Can smoking or alcohol increase the risk of a tonsil mass?

Yes, smoking and heavy alcohol use are significant risk factors for tonsil cancer.

When should I see a doctor for a tonsil mass?

If you notice a persistent or enlarging tonsil mass, especially with pain, difficulty swallowing, or other concerning symptoms, see a doctor promptly.

Summary

FNAC is a useful, minimally invasive diagnostic procedure for tonsil masses, distinguishing between benign and malignant disease with high sensitivity and specificity. FNAC plays an important role in early detection, enabling timely intervention and guiding treatment. Although FNAC has its limitations in the form of sampling challenges and anatomical complexities, its ability to identify malignancies at an early stage can improve patient outcomes. Future developments may include better sampling techniques, more sophisticated imaging for precision, and incorporation of molecular diagnostics to further enhance its efficacy and accuracy in tonsil mass diagnosis.